Atherogenic Plasma Index Levels of Colon Cancer Patients after Chemotherapy
Utku Donem Gundogdu *
Department of Oncology, Afyon Park Hospital, 03200, Afyon, Turkey.
Funda Karabag Çoban
Department of Molecular Biology and Genetics, Usak University, 64200, Usak, Turkey.
*Author to whom correspondence should be addressed.
Abstract
Objectives: Despite newly developed treatment modalities, colorectal cancer is still the leading cause of cancer deaths. In recent years, studies have been carried out to suggest that lipid metabolism may play a role in cancer development and metastasis.
Methods: Lipid metabolism both in conventional chemotherapy. It has also been found that it plays a central role in resistance to targeted therapies. In our study, we planned to compare the atherogenic plasma index levels of patients diagnosed with colon cancer before chemotherapy and in the month of chemotherapy.
Results and Conclusions: Evaluating the effect on the atherogenic plasma index after chemotherapy, we thought that lipid-regulating treatments would contribute to both cancer development and disease control.
Keywords: Atherogenic plasma index, lipoprotein, cancer, colon